Lab TestedLirapic 12mg/3ml 1 Pen by Pharmacona
Lirapic by Pharmacona delivers 12 mg liraglutide in a prefilled injection pen, engineered as a GLP-1 receptor agonist that mimics endogenous incretin signalling to regulate appetite, slow gastric emptying, and stabilise postprandial blood glucose. The single-dose pen format supports precise subcutaneous administration with dial-in dosing control, making it practical for structured weekly titration protocols. Quality is secured at the batch level: each unit passes HPLC-confirmed potency analysis and LAL endotoxin screening under full GMP certification before release.








